| Literature DB >> 31007461 |
Abstract
Current evidence links oxidative stress (OS) to male infertility, reduced sperm motility, sperm DNA damage and increased risk of recurrent abortions and genetic diseases. A review of PubMed, Medline, Google Scholar, and Cochrane review databases of published articles from years 2000-2018 was performed focusing on physiological and pathological consequences of reactive oxygen species (ROS), sperm DNA damage, OS tests, and the association between OS and male infertility, pregnancy and assisted reproductive techniques outcomes. Generation of ROS is essential for reproductive function, but OS is detrimental to fertility, pregnancy, and genetic status of the newborns. Further, there is a lack of consensus on selecting OS test, type, and duration of antioxidants treatment as well as on the target patients group. Developing advanced diagnostic and therapeutic options for OS is essential to improve fertility potential and limit genetic diseases transmitted to offspring.Entities:
Keywords: Antioxidants; male infertility; oxidative stress; sperm DNA damage
Year: 2019 PMID: 31007461 PMCID: PMC6472207 DOI: 10.4103/jhrs.JHRS_150_18
Source DB: PubMed Journal: J Hum Reprod Sci ISSN: 1998-4766
Figure 1Sources of reactive oxygen species in the body and their pathological consequences on semen, fertility and health. ROS = Reactive oxygen species, OS = Oxidative stress
Antioxidant therapy in male infertility
| Author, years | Groups/number of participants | Controlled | Type of antioxidant and dose | Intervention period | Results |
|---|---|---|---|---|---|
| Safarinejad, 2011[ | Idiopathic oligoasthenoteratozoospermia/211 | Yes | EPA and DHA acids, 1.84 g/day versus placebo | 32 weeks | Increase in total sperm count and concentration. Both EPA and DHA positively correlated with plasma superoxide dismutase and catalase activity |
| Wirleitner | Oligoasthenoteratozoospermia and nonoligoasthenoteratozoospermia/147 | Yes | Fertilovit M-Plus | 2 months | Increased sperm concentration and motility. No significant improvement in morphology |
| Safarinejad | Idiopathic oligoasthenoteratozoospermia/228 | Yes | Coenzyme Q10-200 mg per day | 26 weeks | Increased sperm density, motility and morphology. Decreased follicle stimulating hormone activity |
| Safarinejad, 2012[ | Idiopathic oligoasthenoteratozoospermia/287 | No | Coenzyme Q10-300 mg twice daily | 12 months | Increased mean sperm concentration, progressive motility and normal morphology |
| Busetto | Idiopathic asthenoteratozoospermia/114 | No | L-carnitine-145 mg | 4 months | Increased progressive sperm motility, and no significant improvement in sperm concentration and morphology |
| Chen | Oligozoospermia and asthenozoospermia/64 and 42 | Yes | Oligospermia | 3 months | Progressive increase in sperm motility in oligospermic men. There was nonsignificant improvement in sperm motility in asthenozoospermic individuals |
| Cavallini, 2006[ | Idiopathic oligoasthenoteratozoospermia/55 | Yes | L-carnitine 1 g bid | 3 months | Improvement in morphology and number of spermatozoa. Increased percentage of pregnancy following ICSI. Nonsignificant improvement in the number of fertilised oocytes and embryos transferred |
| Abad | Asthenoteratozoospermia/20 | Yes | L-carnitine-1500 mg | 0 h, 2 h, 6 h, 8 h and 24 h | Increase in sperm concentration, motility, vitality and morhological parameters |
| Nadjarzadeh | Idiopathic oligoasthenoteratozoospermia/60 | Yes | 200 mg/day | 3 months | Improved semen parameters |
| Raigani | Oligoasthenoteratozoospermia/83 | Yes | Folic acid (5 mg/day) | 16 weeks | Increased sperm concentration with combined treatment |
| Hadwan | Asthenozoospermia/60 | Yes | Zinc sulfate (220 mg/day) bid | 3 months | Increased in semen volume, sperm count and forward motility |
| Cyrus | Clinical varicocele/115 | Yes | Vitamin C (250 mg) | 3 months | No effect on sperm count but improved sperm motility and morphology |
| Haghighian | Idiopathic asthenozoospermia/44 | Yes | Alpha lipoic acid (600 mg) or placebo | 12 weeks | Sperm count, concentration, and motility were significantly improved |
| ElSheikh | Idiopathic oligoasthenozoospermia/90 | Yes | I: Vitamin E (400 mg/day) | 6 months | There was no significant increase in sperm concentration but only in the Vitamin E group. Combination therapy showed increased sperm concentration and motility |
| Bozhedomov | Oligo or astheno or teratozoospermia/173 | Yes | L-carnitine fumarate (1 g), acetyl L-carnitine (0.5 g) twice daily, combination of Vitamins A, E, C, selenium, zinc, clomiphene (25 mg) bid | 3-4 months | Improve in the concentration of spermatozoa but no effect on sperm morphology, motility and pregnancy rates |
EPA=Eicosapentaenoic acid, DHA=Docosahexaenoic acid, ICSI=Intracytoplasmic sperm injection, GSH=Glutathione
Direct assays of oxidative stress
| Test | Method of measurement | Function | Advantages | Disadvantages |
|---|---|---|---|---|
| Chemilum-inescence assay | Charged or uncharged probes undergo oxidation/reduction with generation of light as by-product | Deduce oxidation or reduction through the generation of light | High sensitivity and specificity. Robust test | Large and expensive equipment |
| Flow cytometry | When excited by light of differing wavelengths, the incubation with the dye emits fluorescence | Measurement of ROS | It requires a small number of spermatozoa - patients with low sperm count- and can measure multiple markers simultaneously | Expensive tool that is not practical for widespread clinical use |
| Electron spin resonance | Obtains the absorption spectra of spin energy among unpaired electrons in an applied magnetic field | Detection of free radicals | Broad usage covering various parameters like: | Free radicals can react with another molecule other than spin-trapping agent |
| Cytochrome c reduction | Superoxide radicals and reduced ferricytochrome c are identified | Evaluation of ROS on the cell membrane | Good in detecting high levels of ROS | If enzyme activity is less, relative insensitivity to the detection of NADPH oxidase activity |
| Nitroblue tetrazolium test | Nitroblue tetrazolium turns yellow to purple/blue when exposed to ROS | Localization of reaction between leukocytes or sperm cells and superoxide ions | Detects neutrophils at a concentration of 0.5×106/mL or higher | Subjective interpretation of a positive or negative neutrophil |
| Thiobarbituric acid assay | Based on the reaction of a chromogenic agent, 2-thiobarbituric acid with MDA | Used to evaluate the resistance of sperm to oxidative stress | Can assess sperm MDA levels | Expensive equipment is required |
| Xylenol orange-based assay | Oxidants in semen samples oxidise the ferrous ion-o-dianisidine complex to ferric ion. Ferric ion forms a colored compound with xylenol that can be detected using a spectrophotometer | Colorimetric automated assay | Measures the net oxidative imbalance between ROS production and antioxidant concentration | Limited widespread utility due to cost |
| FITC-labelled lectins | Used to detect the sperm acrosome status | Used to detect sperm peroxidase using plant lectins labeled with a fluorescent agent (FITC) to detect a group of sperm peroxidases | Detects sperm acrosome status | Difficult to detect true and false acrosome reaction |
ROS=Reactive oxygen species, MDA=Malondialdehyde, NADPH=Nicotinamide adenine dinucleotide phosphate, FITC=Fluorescein isothiocyanate
Indirect assays of oxidative stress
| Test | Method of measurement | Function | Advantages | Disadvantages |
|---|---|---|---|---|
| Myeloperoxidase or Endtz test | Peroxidase positivity is assessed through staining using benzidine as a buffer | Detection of granulocytes in semen | Specifically distinguishes WBC’s especially producing granulocytes from immature germ cells in semen | Cannot be used to detect ROS production in spermatozoa |
| Lipid peroxidation levels | Detection of MDA and toxic 4-HNE through colorimetric and thiobarbituric acid assays | Identification of by-products of lipid peroxidation | MDA is a colored substance that can be measured by fluorometry or spectrophotometry. Low sperm concentration of MDA can be measured through sensitive HPLC equipment or spectrofluorometric measurement of iron-based promoters | Not a widely-used test in clinic practice |
| MiOXSYs | Assessment of electron transfer in millivolts from a reducing agent to the oxidant using a galvanostat-based system | Measurement of oxidation-reduction potential | Easy to employ in a clinical setting | Larger cohort studies to establish the reference value are needed |
| Total antioxidant capacity | Evaluates the reductive ability of the antioxidants within the semen against an oxidative agent such as hydrogen peroxide and measures the effect on the substrate | Assesses the cumulative effect of antioxidants within the semen | Rapid colorimetric method | Does not measure individual or enzymatic antioxidants. Requires expensive assay kit and microplate reader |
| Gpx activity | The activity of Gpx is measured by the decrease in GSH content after incubating the sample in the presence of H2O2 and NaN3 | Based on the principle that Gpx catalyzes the reaction between hydrogen peroxide and reduced GSH | Gpx protects the sperm from lipid peroxidation and the DNA damage can be significant if the Gpx levels are lower | Some studies show that Gpx activity does not correlate with sperm motility or concentration |
| Comet assay | Allows DNA migration in an agarose gel under an electric field. The loose DNA forms a pattern of migration that resembles a comet | Single-cell gel electrophoresis assay to assess DNA damage | Can detect extent of DNA damage equivalent to 50-single strand breaks per cell | No consensus reached on the standardization protocol |
GSH=Glutathione, GPx=GSH peroxidase, 4-HNE=4-hydorxynonenal, MDA=Malondialdehyde, WBC’s=White blood cells, ROS=Reactive oxygen species, HPLC=High-performance liquid chromatography